Showing results (61-70 of 912) with videos related to
Sort By:
Pageof 92
Clinical Calcium|April 28, 2016
[Mechanism of bone destruction in rheumatoid arthritis and perspectives of the treatment]Takuma Koyama, Sakae TanakaArthritis Research & Therapy|May 17, 2017
Molecular mechanisms underlying osteoarthritis development: Notch and NF-κBTaku Saito, Sakae TanakaThe Journal of Clinical Investigation|September 23, 2009
NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesisSakae Tanaka, Hiroyasu NakanoJournal of Bone and Mineral Metabolism|October 18, 2020
RANKL as a therapeutic target of rheumatoid arthritisSakae Tanaka, Yoshiya TanakaJournal of Bone and Mineral Metabolism|November 18, 2020
Sclerostin: from bench to bedsideSakae Tanaka, Toshio MatsumotoArchivum Immunologiae Et Therapiae Experimentalis|June 3, 2011
Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biologyToru Akiyama, Sakae TanakaThe Journal of Clinical Investigation|September 18, 2009
The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in miceMitsuyasu Iwasawa, Tsuyoshi Miyazaki, Yuichi Nagase, et al.The Journal of Biological Chemistry|October 23, 2009
Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclastsYuichi Nagase, Mitsuyasu Iwasawa, Toru Akiyama, et al.Pageof 92